Enlivex CEO discloses initial share and option stakes

Enlivex Ltd. Chief Executive Officer Oren Hershkovitz filed an initial ownership report showing his current equity position in the company.

Rhea-AI Filing Summary

Enlivex Ltd. Chief Executive Officer Oren Hershkovitz filed an initial ownership report showing his current equity position in the company. He directly holds 172,855 Ordinary Shares, each with a par value of NIS 0.40.

He also holds employee stock options to acquire 150,000 Ordinary Shares at an exercise price of $8.19 per share that expire on December 31, 2033, and options to acquire an additional 60,000 Ordinary Shares at an exercise price of $5.34 per share that expire on November 17, 2032. This filing does not reflect new purchases or sales but establishes his existing holdings.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Hershkovitz Oren

Role Chief Executive Officer

Type	Security	Shares	Price	Value
holding	Employee Stock Option (right to buy)	--	--	--
holding	Employee Stock Option (right to buy)	--	--	--
holding	Ordinary Shares, par value NIS 0.40 per share	--	--	--

Holdings After Transaction: Employee Stock Option (right to buy) — 210,000 contracts (Direct); Ordinary Shares, par value NIS 0.40 per share — 172,855 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Enlivex (ENLV) CEO Oren Hershkovitz report owning in this Form 3?

He reports direct ownership of 172,855 Ordinary Shares of Enlivex Ltd. The filing also lists his employee stock options, which give him the right to acquire additional Ordinary Shares at preset exercise prices before their expiration dates.

How many Enlivex (ENLV) options does the CEO hold and at what prices?

He holds options over 150,000 Ordinary Shares at an exercise price of $8.19 and options over 60,000 Ordinary Shares at $5.34. These options represent potential future share acquisitions if he chooses to exercise them.

When do the Enlivex (ENLV) CEO’s stock options reported on Form 3 expire?

The 150,000-share option grant expires on December 31, 2033, and the 60,000-share grant expires on November 17, 2032. After these dates, he can no longer exercise those specific options for Ordinary Shares.

Does this Enlivex (ENLV) Form 3 show the CEO buying or selling shares?

No, the Form 3 indicates holding entries only, with no reported buys or sells. It serves as an initial statement of beneficial ownership, establishing the CEO’s existing share and option position at the reporting date.

What type of securities are reported in the Enlivex (ENLV) CEO’s Form 3?

The report covers Ordinary Shares, par value NIS 0.40 per share, and Employee Stock Options (rights to buy) over those Ordinary Shares. All positions are reported as directly owned by the Chief Executive Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:15 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hershkovitz Oren

(Last) (First) (Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA 7403618

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	172,855	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	11/16/2023	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	150,000	$8.19	D
Employee Stock Option (right to buy)	11/24/2025	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	60,000	$5.34	D

Explanation of Responses:

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Shachar Shlosberger	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)